SCYNEXIS, Inc. Accrued Bonuses, Current
SCYNEXIS, Inc. (SCYX) had Accrued Bonuses, Current of $863.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Notes › Accrued Liabilities, Current
us-gaap:AccruedBonusesCurrent · last filed 2026-08-10
- 2026-06-30: Accrued Bonuses, Current $863.00K.
- 2026-03-31: Accrued Bonuses, Current $420.00K.
- 2025-12-31: Accrued Bonuses, Current $1.51M.
- 2025-09-30: Accrued Bonuses, Current $1.18M.
| Period end | Accrued Bonuses, Current |
|---|---|
| 2026-06-30 | $863.00K 10-Q · filed 2026-08-10 |
| 2026-03-31 | $420.00K 10-Q · filed 2026-05-11 |
| 2025-12-31 | $1.51M 10-Q · filed 2026-08-10 |
| 2025-09-30 | $1.18M 10-Q · filed 2025-11-05 |
| 2025-06-30 | $834.00K 10-Q · filed 2025-08-13 |
| 2025-03-31 | $477.00K 10-Q · filed 2025-05-15 |
| 2024-12-31 | $1.76M 10-K · filed 2026-03-04 |
| 2024-09-30 | $1.34M 10-Q · filed 2024-11-06 |
| 2024-06-30 | $906.00K 10-Q · filed 2024-08-08 |
| 2024-03-31 | $453.00K 10-Q · filed 2024-05-08 |
| 2023-12-31 | $1.69M 10-K · filed 2025-03-12 |
| 2023-09-30 | $1.45M 10-Q · filed 2023-11-13 |
| 2023-06-30 | $996.00K 10-Q · filed 2023-08-14 |
| 2023-03-31 | $498.00K 10-Q · filed 2023-05-10 |
| 2022-12-31 | $1.63M 10-K · filed 2024-03-28 |
| 2022-09-30 | $1.82M 10-Q · filed 2022-11-09 |
| 2022-06-30 | $1.16M 10-Q · filed 2022-08-15 |
| 2022-03-31 | $505.00K 10-Q · filed 2022-05-12 |
| 2021-12-31 | $2.01M 10-K · filed 2023-03-31 |
| 2021-09-30 | $1.51M 10-Q · filed 2021-11-10 |
| 2021-06-30 | $935.00K 10-Q · filed 2021-08-16 |
| 2021-03-31 | $433.00K 10-Q · filed 2021-05-17 |
| 2020-12-31 | $2.19M 10-K · filed 2022-03-29 |
| 2020-09-30 | $1.15M 10-Q · filed 2020-11-06 |
| 2020-06-30 | $759.00K 10-Q · filed 2020-08-10 |
| 2020-03-31 | $365.00K 10-Q · filed 2020-05-11 |
| 2019-12-31 | $1.80M 10-K · filed 2021-03-29 |
| 2019-09-30 | $1.06M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $684.00K 10-Q · filed 2019-08-07 |
| 2019-03-31 | $325.00K 10-Q · filed 2019-05-08 |
| 2018-12-31 | $1.20M 10-K · filed 2020-03-11 |
| 2018-09-30 | $795.00K 10-Q · filed 2018-11-13 |
| 2018-06-30 | $522.00K 10-Q · filed 2018-08-09 |
| 2018-03-31 | $261.00K 10-Q · filed 2018-05-08 |
| 2017-12-31 | $763.00K 10-K · filed 2019-03-14 |
| 2017-09-30 | $643.00K 10-Q · filed 2017-11-07 |
| 2017-06-30 | $421.00K 10-Q · filed 2017-08-08 |
| 2017-03-31 | $203.00K 10-Q · filed 2017-05-08 |
| 2016-12-31 | $730.00K 10-K · filed 2018-03-13 |
| 2016-09-30 | $569.00K 10-Q · filed 2016-11-07 |
| 2016-06-30 | $413.00K 10-Q · filed 2016-08-08 |
| 2016-03-31 | $215.00K 10-Q · filed 2016-05-09 |
| 2015-12-31 | $776.00K 10-K · filed 2017-03-13 |
| 2014-12-31 | $1.46M 10-K · filed 2016-03-07 |
| 2013-12-31 | $0.00 8-K · filed 2015-10-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| VERU INC. (VERU) | United States | $0.043B | -3.93 |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |